Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 16.10
0.00 (0.00%)
Apr 24, 2026, 1:44 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 21.58 million as of April 24, 2026. Its market cap has decreased by -43.38% in one year.
Market Cap
21.58M
Enterprise Value
17.15M
Revenue
19.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.10
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 21.58M, a decrease of -63.92%. That is a compound annual growth rate of -4.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 21.58M | -3.59% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 108.98B |
| Danel (Adir Yeoshua) | 2.86B |
| Amal Holdings A.D. | 2.41B |
| BrainsWay | 1.93B |
| Evogene | 29.38M |
| BioLight Life Sciences | 24.18M |
| Erika Carmel-Tech | 20.10M |
| Can-Fite BioPharma | 19.82M |